β₁-Adrenoceptor Arg389Gly Polymorphism Confers Differential β-Arrestin-Binding Tropism in Cardiac Myocytes

References

• Lymperopoulos A , GarciaD , WalklettK . Pharmacogenetics of cardiac inotropy . Pharmacogenomics15 , 1807 – 1821 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Capote LA , Mendez PerezR , LymperopoulosA . GPCR signaling and cardiac function . Eur. J. Pharmacol.763 , 143 – 148 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lymperopoulos A , RengoG , KochWJ . Adrenergic nervous system in heart failure: pathophysiology and therapy . Circ. Res.113 , 739 – 753 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• McCrink KA , LymperopoulosA . β1-adrenoceptor Arg389Gly polymorphism and heart disease: marching toward clinical practice integration . Pharmacogenomics16 , 1035 – 1038 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ahles A , EngelhardtS . Polymorphic variants of adrenoceptors: pharmacology, physiology, and role in disease . Pharmacol. Rev.66 , 598 – 637 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Dorn GW . Adrenergic signaling polymorphisms and their impact on cardiovascular disease . Physiol. Rev.90 ( 3 ), 1013 – 1062 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Mialet Perez J , RathzDA , PetrashevskayaNNet al. Beta1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure . Nat. Med.9 ( 10 ), 1300 – 1305 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Rochais F , VilardagaJP , NikolaevVOet al. Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol . J. Clin. Invest.117 ( 1 ), 229 – 235 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Sandilands AJ , O’ShaughnessyKM , BrownMJ . Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 beta 1-adrenoceptors versus Gly389 beta 1-adrenoceptors in isolated human atrial myocardium . Br. J. Pharmacol.138 ( 2 ), 386 – 392 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Liggett SB , Mialet-PerezJ , Thaneemit-ChenSet al. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure . Proc. Natl Acad. Sci. USA103 ( 30 ), 11288 – 11293 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Wang H , LiuJ , LiuKet al. β1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population: a meta-analysis . Mol. Biol. Rep.40 ( 6 ), 4055 – 4063 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Horikoshi M , YaghootkarH , Mook-KanamoriDOet al. New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism . Nat. Genet.45 ( 1 ), 76 – 82 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yilmaz A , KayaMG , MerdanogluUet al. Association of beta-1 and beta-2 adrenergic receptor gene polymorphisms with myocardial infarction . J. Clin. Lab. Anal.23 ( 4 ), 237 – 243 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Fragoso JM , Rodríguez-PérezJM , GonzálezJet al. Beta1-adrenergic receptor gene polymorphisms in Mexican patients with idiopathic dilated cardiomyopathy . Exp. Mol. Pathol.80 ( 3 ), 279 – 282 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Iwai C , AkitaH , ShigaNet al. Suppressive effect of the Gly389 allele of the beta1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy . Circ. J.66 ( 8 ), 723 – 728 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Huntgeburth M , La RoséeK , ten FreyhausHet al. The Arg389Gly β1-adrenoceptor gene polymorphism influences the acute effects of β-adrenoceptor blockade on contractility in the human heart . Clin. Res. Cardiol.100 ( 8 ), 641 – 647 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kindermann M , SeelandU , RuhnkeP , BöhmM , MaackC . Functional effects of β1-adrenoceptor polymorphisms on the hemodynamic response to dobutamine with and without β-blocker administration . Clin. Res. Cardiol.100 ( 2 ), 129 – 137 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Liu WN , FuKL , GaoHYet al. β1 adrenergic receptor polymorphisms and heart failure: a meta-analysis on susceptibility, response to β-blocker therapy and prognosis . PLoS ONE7 ( 7 ), e37659 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Taylor MR , SunAY , DavisGet al. Race, common genetic variation, and therapeutic response disparities in heart failure . JACC Heart Fail.2 ( 6 ), 561 – 572 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ahles A , RodewaldF , RochaisFet al. Interhelical interaction and receptor phosphorylation regulate the activation kinetics of different human β1-adrenoceptor variants . J. Biol. Chem.290 , 1760 – 1769 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lymperopoulos A , BathgateA . Arrestins in the cardiovascular system . Prog. Mol. Biol. Transl. Sci.118 , 297 – 334 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lymperopoulos A , NegussieS . βarrestins in cardiac G protein-coupled receptor signaling and function: partners in crime or “good cop, bad cop”?Int. J. Mol. Sci.14 ( 12 ), 24726 – 24741 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Luttrell LM , Gesty-PalmerD . Beyond desensitization: physiological relevance of arrestin-dependent signaling . Pharmacol. Rev.62 , 305 – 330 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Srivastava A , GuptaB , GuptaCet al. Emerging functional divergence of β-arrestin isoforms in GPCR function . Trends Endocrinol. Metab.26 , 628 – 642 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Conner DA , MathierMA , MortensenRMet al. beta-arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation . Circ. Res.81 , 1021 – 1026 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Bathgate-Siryk A , DabulS , PandyaKet al. Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms . Hypertension63 , 404 – 412 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Watari K , NakayaM , NishidaMet al. β-arrestin2 in infiltrated macrophages inhibits excessive inflammation after myocardial infarction . PLoS ONE8 , e68351 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Morisco C , ZebrowskiDC , VatnerDEet al. Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart . J. Mol. Cell. Cardiol.33 , 561 – 573 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Lymperopoulos A , RengoG , ZincarelliCet al. An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo . Proc. Natl Acad. Sci. USA106 ( 14 ), 5825 – 5830 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lymperopoulos A , RengoG , ZincarelliCet al. Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels . J. Am. Coll. Cardiol.57 ( 3 ), 356 – 365 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Salazar NC , VallejosX , SirykAet al. GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility . Cell. Commun. Signal.11 , 64 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lymperopoulos A , RengoG , FunakoshiHet al. Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure . Nat. Med.13 , 315 – 323 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Jafferjee M , Reyes ValeroT , MarreroCet al. GRK2 up-regulation creates a positive feedback loop for catecholamine production in chromaffin cells . Mol. Endocrinol.30 ( 3 ), 372 – 381 ( 2016 ).
   PubMedGoogle Scholar
• Clements M , MillarV , WilliamsASet al. Bridging functional and structural cardiotoxicity assays using human embryonic stem cell-derived cardiomyocytes for a more comprehensive risk assessment . Toxicol. Sci.148 ( 1 ), 241 – 260 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Morisco C , MarroneC , GaleottiJet al. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes . Cardiovasc. Res.78 ( 1 ), 36 – 44 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Wisler JW , DeWireSM , WhalenEJet al. A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling . Proc. Natl. Acad. Sci. USA104 , 16657 – 16662 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Liu JJ , HorstR , KatritchVet al. Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR . Science335 , 1106 – 1110 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lefkowitz RJ , ShenoySK . Transduction of receptor signals by β-arrestins . Science308 , 512 – 517 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Gurevich VV , GurevichEV . The structural basis of arrestin-mediated regulation of G-protein-coupled receptors . Pharmacol. Ther.110 ( 3 ), 465 – 502 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Lymperopoulos A , BathgateA . Pharmacogenomics of the heptahelical receptor regulators G-protein-coupled receptor kinases and arrestins: the known and the unknown . Pharmacogenomics13 ( 3 ), 323 – 341 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bristow MR , GinsburgR , UmansVet al. β1-and β2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective β1-receptor down-regulation in heart failure . Circ. Res.59 , 297 – 309 ( 1986 ).
   PubMed Web of Science ®Google Scholar
• Ungerer M , ParrutiG , BöhmMet al. Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart . Circ. Res.74 , 206 – 213 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Eichel K , JulliéD , von ZastrowM . β-Arrestin drives MAP kinase signalling from clathrin-coated structures after GPCR dissociation . Nat. Cell Biol.18 ( 3 ), 303 – 310 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Remme WJ , Torp-PedersenC , ClelandJGet al. Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET . J. Am. Coll. Cardiol.49 ( 9 ), 963 – 971 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Bozkurt B , BolosM , DeswalAet al. New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients-a matter of time for contractility . J. Card. Fail.18 , 183 – 193 ( 2012 ).
   PubMed Web of Science ®Google Scholar